KEMPHARM a buy ?

www.kempharm.com/pages/pipeline/index.php

www.nasdaq.com/de/symbol/kmph/real-time

Aktuell: $4.8899
*  
0.5799
13.45%

sleekmoney.com/...ation-of-strong-buy-from-brokerages/1489196/

www.streetinsider.com/Corporate+News//...eatment/12048275.html

www.reuters.com/article/...says-presents-clinica-idUSFWN1GT0EM

seekingalpha.com/article/...esents-29th-annual-roth-conference

www.nasdaq.com/de/symbol/kmph/real-time

www.analystratings.com/articles/...ing-from-canaccord-genuity/

www.benzinga.com/news/18/07/11992309/...afety-trial-endpoints

www.insidermonkey.com/blog/...arm-inc-kmph-and-more-666565/2/

25 Mio. $ Offering

"CORALVILLE, Iowa, Oct. 05, 2018 -- KemPharm, Inc., a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced the pricing of its underwritten public offering of 8,333,334 shares of its common stock at a price to the public of $3.00 per share.  In addition, KemPharm has granted to the underwriters a 30-day option to purchase up to 1,250,000 additional shares of common stock at the public offering price, less the underwriting discount. The offering is expected to close on or about October 10, 2018, subject to customary closing conditions."

investors.kempharm.com/news-releases/...-offering-common-stock

Kempharm meldet Zahlen für 2018

• keine Umsätze
  
• Verlust 56 Mio. $
  
• Cash 18 Mio. $
  
• negatives Eigenkapital (-67 Mio. $)
  
• MK 45 Mio. $
  

investors.kempharm.com/news-releases/...q4-and-fy-2018-results

seekingalpha.com/news/...nt-hours-kp415-nda-nears-finish-line

• neues 52 Wochen-Tief
  
• 1. Kommentar lesen auf SA
  

seekingalpha.com/news/...nt-hours-kp415-nda-nears-finish-line

• neues 52 Wochen-Tief
  
• Finger weg
  

weiter abwärts

wieder ein neues Tief!
seekingalpha.com/news/...premarket-license-deal-debt-exchange

seekingalpha.com/news/3506359-kempharm-files-80m-mixed-shelf

Oder was in der Pipeline?

Nicht das ich wüsste. Die Kursentwicklung spricht Bände.

seekingalpha.com/article/...-results-earnings-call-transcript

Nasdaq Delisting

www.sec.gov/Archives/edgar/data/1434647/...mph20200519_8k.htm

Meldung? Es ist ein Prospekt, aber Deerfield, ein Kreditgeber verlängert seinen Kredit bis 2023 gegen Zinszahlung von 6,75 Prozent. Wird der Kredit von Deerfield in Aktien umgetauschtP Oder bekommt Deerfield die Aktien und Warrants zu 0,97 Dollar als Anreiz, den Kredit zu verlängern. Ich kann die news einfach nicht bewerten/einschätzen ...